On 10-11 October the 4th annual event Outsourcing in Clinical Trials Nordics will be returning to the capital of Denmark.
The 2 day event last September saw over 150 delegates working on clinical trials from pharmaceutical, biotech and medical device companies come together to discuss the industry’s biggest operational and outsourcing challenges. The streamed agenda allows delegates to tailor their day and during the networking sessions delegates are able to meet service providers and colleagues.
The first session has the topic Boosting clinical trial activity in the Nordics and among the speakers are Britta Smedegaard Andersen, Project Director, NEXT Partnership and Lene Grejs Petersen, Senior Advisor, Danish Medicines Agency. Under the headline Clinical trial innovation and technology subjects like Unravelling an effective strategy to prepare for the transition to clinical, Exploring best practices for SDV and quantitative experience in Risk Based Monitoring and Moving clinical trial technology beyond the hype and into reality in the Nordics will be handled. Speakers in this session include William Dalby-Brown, COO, CaDo Biotechnology, Rich Davies, Executive Director of Business Solutions, OmniComm Systems, Inc, Annu Suchdev, Head of Quality R&D and HCC, Sobi AB and Anette Østergaard, VP Clinical Development, MC2 Biotek.
The first day will end with the subject of Patient centricity and engagement, and speakers include Pia Søegaard Andersen, Director, Product Strategy, Life Sciences, Lionbridge, Ninette, Neel Florboe, Anthropologist, EUPATi, Lasse Funch Jacobsen, Associate Network Director – Patients Relations, Novo Nordisk, Amy Martinsen, Research Coordinator, Oslo University Hospital and Lotte Seiding Larsen, Principal Scientific Advisor, Leo Pharma.
The second day will be divided up into a Biotech & Pharma stream and a Med Devices stream, including both case studies and panel discussion. In the Pharma/Biotech stream topics like Effective communication and relationship management in extended teams and Readiness for 536/2014/CE and ICH GCP EC6 R2 will be discussed. The Med Device stream will discuss topics like The pros and cons of standardization of medical device and In vitro diagnostic (IVD) device regulations and A holistic approach to compliance and oversight in med device trials. The event will end with interactive roundtable sessions, hosted by industry experts and each focused on a single issue.
Photo showing from left: Annu Suchdev, Head of Quality R&D and HCC, Sobi AB and Britta Smedegaard Andersen, Project Director, NEXT Partnership
